CTCBIO Inc. (KOSDAQ:060590)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,365.00
+85.00 (2.59%)
At close: Aug 11, 2026

CTCBIO Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
128,758123,769119,877137,878165,206140,318
Other Revenue
-0-0-0-0-0-0
128,758123,769119,877137,878165,206140,318
Revenue Growth
6.09%3.25%-13.06%-16.54%17.74%7.91%
Cost of Revenue
76,58173,81070,64495,309111,150107,228
Gross Profit
52,17749,95949,23242,57054,05633,090
Selling, General & Admin
40,70942,17248,28041,89437,19131,962
Research & Development
1,6201,7853,5582,6392,4143,090
Amortization of Goodwill & Intangibles
67.6366.1781.9396.74296.67414.05
Other Operating Expenses
271.4270.06317.14264.6208.57231.86
Operating Expenses
42,22443,70954,24647,14842,82636,027
Operating Income
9,9536,250-5,014-4,57811,230-2,938
Interest Expense
-2,239-2,317-2,846-3,244-2,895-3,647
Interest & Investment Income
297.29307.85520.97725.08251.11118.76
Currency Exchange Gain (Loss)
-1,082-1,382996.6641.68-470.14-533.35
Other Non Operating Income (Expenses)
-220.6766.551,771689.17-2,3741,952
EBT Excluding Unusual Items
6,7092,925-4,571-6,3675,741-5,047
Gain (Loss) on Sale of Investments
---186.4-201.64-320.2-708.55
Gain (Loss) on Sale of Assets
318.54321.68137.86264.89-40.551.28
Asset Writedown
-268.5-268.5-689.52-9,411-5,181-1,337
Other Unusual Items
----0.01-595.12
Pretax Income
6,7592,978-5,309-15,715199.42-7,687
Income Tax Expense
641.56-289.6-102.59-126.83-4,504291.74
Earnings From Continuing Operations
6,1173,268-5,206-15,5884,704-7,978
Earnings From Discontinued Operations
-11.88-27.15-14.05---
Net Income to Company
6,1053,241-5,220-15,5884,704-7,978
Minority Interest in Earnings
-----660.21
Net Income
6,1053,241-5,220-15,5884,704-7,318
Net Income to Common
6,1053,241-5,220-15,5884,704-7,318
Net Income Growth
------
Shares Outstanding (Basic)
242424242422
Shares Outstanding (Diluted)
242424242422
Shares Change
-1.24%-0.16%0.16%0.38%7.17%11.67%
EPS (Basic)
256.75135.54-218.00-651.97197.49-329.29
EPS (Diluted)
256.75135.54-218.00-652.00197.00-329.29
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
9,8813,5972,3576,33115,0514,783
Free Cash Flow Per Share
415.52150.4398.42264.80631.92215.23
Gross Margin
40.52%40.37%41.07%30.88%32.72%23.58%
Operating Margin
7.73%5.05%-4.18%-3.32%6.80%-2.09%
Profit Margin
4.74%2.62%-4.35%-11.31%2.85%-5.21%
Free Cash Flow Margin
7.67%2.91%1.97%4.59%9.11%3.41%
EBITDA
16,39412,781891.051,36817,9363,344
EBITDA Margin
12.73%10.33%0.74%0.99%10.86%2.38%
D&A For EBITDA
6,4416,5325,9055,9476,7066,282
EBIT
9,9536,250-5,014-4,57811,230-2,938
EBIT Margin
7.73%5.05%-4.18%-3.32%6.80%-2.09%
Effective Tax Rate
9.49%-----
Advertising Expenses
-1,0611,1751,055636.46722.54